Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusion

Ahmet Emre Eşkazan, Deniz Eyice Karabacak, Enes Ali Kurt, +10

Leukemia Research

Hematological MalignancyOncologyMixed-phenotype Acute LeukemiaSecond-line DasatinibHematology +7

Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey

Ayşe Salihoğlu, Tuğrul Elverdi, Ìhsan Karadoǧan, +15

Annals of Hematology

Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec

Ahmet Emre Eşkazan, Sevil Sadri, Dilek Keskin, +16

Clinical Lymphoma Myeloma & Leukemia

Hematological MalignancyEarly Molecular ResponseOncologyMixed-phenotype Acute LeukemiaMalignant Blood Disorder +8

The role of 68Ga-DOTA-TATE PET/CT scanning in the evaluation of patients with multiple myeloma

Kerim Sönmezoğlu, Betül Vatankulu, Tuğrul Elverdi, +5

Nuclear Medicine Communications

Brentuximab vedotin consolidation therapy after autologous stem‐cell transplantation in patients with high‐risk Hodgkin lymphoma: Multicenter retrospective study

Olga Meltem Akay, Murat Özbalak, Mustafa Pehlıvan, +26

Hematological Oncology

Deep sequencing of <i>BCR-ABL1</i> kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors

Yücel Erbilgin, Ahmet Emre Eşkazan, Özden Hatırnaz Ng, +12

Leukemia & lymphoma/Leukemia and lymphoma

EngineeringMixed-phenotype Acute LeukemiaKinase InhibitorsPathologyTherapy Failure +16

mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity—Does it matter?

Melih Tütüncü, Serkan Demir, Gökhan Arslan, +28

Multiple Sclerosis and Related Disorders

VaccinationVaccine DevelopmentImmunologyImmunodominanceVirus Covid-19 Vaccines +9

The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years

Ali Bazarbachi, Ariane Boumendil, Hervé Finel, +20

Leukemia

Lymphoid NeoplasiaHodgkin LymphomaTransplantationMarrow TransplantationMedicine +8

Retrospective Evaluation of Hairy Cell Leukemia Patients Treated with Three Different First-Line Treatment Modalities in the Last Two Decades: A Single-Center Experience

Şeniz Öngören, Ahmet Emre Eşkazan, Selin Berk, +7

Turkish Journal of Hematology

Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic country

Ahmet Murt, Tuğrul Elverdi, Ahmet Emre Eşkazan, +5

Annals of Hematology